[![darunavir structure](https://www.DrugPatentWatch.com/img/drug-structure/darunavir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/darunavir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog)
Darunavir is the generic ingredient in two branded drugs marketed by Janssen Prods, Lupin Ltd, and Teva Pharms Usa and, and is included in four NDAs. There are two patents protecting this compound.
Three suppliers are listed for this compound. There are eight tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com